In crowded field of psychedelic startups, Filament CEO makes

A recent boom in psychedelic research has given way to a bumper crop of startups seeking to harness the potential of mind-altering drugs for treating depression, addiction and other conditions.

Related Keywords

Gabon , Benjamin Lightburn , Filament Health , Associated Press , Vancouver Based Filament Health , West Africa , Business , News , Addiction , Ceos , Psychedelics ,